H

HaTay Pharmaceutical JSC
VN:DHT

Watchlist Manager
HaTay Pharmaceutical JSC
VN:DHT
Watchlist
Price: 94 900 VND -0.42%
Market Cap: 7.8T VND
Have any thoughts about
HaTay Pharmaceutical JSC?
Write Note

HaTay Pharmaceutical JSC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HaTay Pharmaceutical JSC
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
H
HaTay Pharmaceutical JSC
VN:DHT
Operating Income
â‚«72B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
4%
I
Imexpharm Corp
VN:IMP
Operating Income
â‚«335.4B
CAGR 3-Years
13%
CAGR 5-Years
16%
CAGR 10-Years
14%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Operating Income
â‚«70.7B
CAGR 3-Years
15%
CAGR 5-Years
43%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Operating Income
â‚«189.9B
CAGR 3-Years
2%
CAGR 5-Years
-18%
CAGR 10-Years
2%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Operating Income
â‚«811.6B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
2%
T
Traphaco JSC
VN:TRA
Operating Income
â‚«282.7B
CAGR 3-Years
-21%
CAGR 5-Years
-5%
CAGR 10-Years
3%
No Stocks Found

HaTay Pharmaceutical JSC
Glance View

Market Cap
7.8T VND
Industry
Pharmaceuticals

Ha Tay Pharmaceutical JSC engages in the manufacture, import and export of drugs, medicine, cosmetic and medical equipment. The company is headquartered in Hanoi, Hanoi. The company went IPO on 2008-12-03. The company is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The firm also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The firm announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.

DHT Intrinsic Value
18 592.65 VND
Overvaluation 80%
Intrinsic Value
Price
H

See Also

What is HaTay Pharmaceutical JSC's Operating Income?
Operating Income
72B VND

Based on the financial report for Sep 30, 2024, HaTay Pharmaceutical JSC's Operating Income amounts to 72B VND.

What is HaTay Pharmaceutical JSC's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was -41%. The average annual Operating Income growth rates for HaTay Pharmaceutical JSC have been -8% over the past three years , -10% over the past five years , and 4% over the past ten years .

Back to Top